2022 annual financial data
Cullinan Therapeutics 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was 144,648,000 USD and net income was 111,214,000 USD.
Operating cash flow was -126,664,000 USD.
Get free Cullinan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- 144,648,000 USD
- Net income
- 111,214,000 USD
- Operating cash flow
- -126,664,000 USD